A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants

Clinical trial NCT06144697 · TERMINATED

Trial details

NCT number: NCT06144697
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-01-29
Primary completion: 2024-10-16
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.